Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hermann Haller

Showing results (41-50 of 570) with videos related to

Pageof 57
Sort By:
The EMBO Journal|May 13, 2005
Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-betaJulia Kiyan, Roman Kiyan, Hermann Haller, et al.
Transplantation|December 31, 2010
The effect of cinacalcet on bone remodeling and renal function in transplant patients with persistent hyperparathyroidismAnke Schwarz, Saskia Merkel, Holger Leitolf, et al.
Kidney International|July 16, 2004
Long-term effects of acute ischemia and reperfusion injuryFaikah Gueler, Winfried Gwinner, Anke Schwarz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 12, 2007
Heavy metal--rely on gut feelings: novel diagnostic approach to test drug compliance in patients with lanthanum intakeSascha David, Timm Kirchhoff, Hermann Haller, et al.
Diabetes Care|November 21, 2018
CKD273 Enables Efficient Prediction of Diabetic Nephropathy in Nonalbuminuric PatientsPetra Zürbig, Harald Mischak, Jan Menne, et al.
Kidney International|October 15, 2011
Recent outbreak of hemolytic uremic syndrome in GermanyUlrich Kunzendorf, Helge Karch, Dirk Werber, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 26, 2004
Severe hypokalaemia: is one reason enough?Alexander Woywodt, Alena Herrmann, Hermann Haller, et al.
Journal of Vascular Research|November 23, 2012
Urokinase receptor mediates doxorubicin-induced vascular smooth muscle cell senescence via proteasomal degradation of TRF2Mahshid Hodjat, Hermann Haller, Inna Dumler, et al.
Current Hypertension Reports|April 27, 2016
Finerenone: a New Mineralocorticoid Receptor Antagonist Without Hyperkalemia: an Opportunity in Patients with CKD?Hermann Haller, Anna Bertram, Klaus Stahl, et al.
The Biochemical Journal|August 21, 2009
Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane raftsJulia Kiyan, Graham Smith, Hermann Haller, et al.
Pageof 57

Showing results (41-50 of 570) with videos related to

Sort By:
Pageof 57
The EMBO Journal|May 13, 2005
Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-betaJulia Kiyan, Roman Kiyan, Hermann Haller, et al.
Transplantation|December 31, 2010
The effect of cinacalcet on bone remodeling and renal function in transplant patients with persistent hyperparathyroidismAnke Schwarz, Saskia Merkel, Holger Leitolf, et al.
Kidney International|July 16, 2004
Long-term effects of acute ischemia and reperfusion injuryFaikah Gueler, Winfried Gwinner, Anke Schwarz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 12, 2007
Heavy metal--rely on gut feelings: novel diagnostic approach to test drug compliance in patients with lanthanum intakeSascha David, Timm Kirchhoff, Hermann Haller, et al.
Diabetes Care|November 21, 2018
CKD273 Enables Efficient Prediction of Diabetic Nephropathy in Nonalbuminuric PatientsPetra Zürbig, Harald Mischak, Jan Menne, et al.
Kidney International|October 15, 2011
Recent outbreak of hemolytic uremic syndrome in GermanyUlrich Kunzendorf, Helge Karch, Dirk Werber, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 26, 2004
Severe hypokalaemia: is one reason enough?Alexander Woywodt, Alena Herrmann, Hermann Haller, et al.
Journal of Vascular Research|November 23, 2012
Urokinase receptor mediates doxorubicin-induced vascular smooth muscle cell senescence via proteasomal degradation of TRF2Mahshid Hodjat, Hermann Haller, Inna Dumler, et al.
Current Hypertension Reports|April 27, 2016
Finerenone: a New Mineralocorticoid Receptor Antagonist Without Hyperkalemia: an Opportunity in Patients with CKD?Hermann Haller, Anna Bertram, Klaus Stahl, et al.
The Biochemical Journal|August 21, 2009
Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane raftsJulia Kiyan, Graham Smith, Hermann Haller, et al.
Pageof 57